After finishing at $0.12 in the prior trading day, TNF Pharmaceuticals Inc (NASDAQ: TNFA) closed at $0.12, up 7.02%. In other words, the price has increased by $7.02 from its previous closing price. On the day, 58.61 million shares were traded. TNFA stock price reached its highest trading level at $0.1291 during the session, while it also had its lowest trading level at $0.116.
Ratios:
Our goal is to gain a better understanding of TNFA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.37 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNFA now has a Market Capitalization of 1773012 and an Enterprise Value of 1190257.
Stock Price History:
The Beta on a monthly basis for TNFA is 1.84, which has changed by -0.9352332 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, TNFA has reached a high of $2.16, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is -11.86%, while the 200-Day Moving Average is calculated to be -81.83%.
Shares Statistics:
The stock has traded on average 19.65M shares per day over the past 3-months and 98456850 shares per day over the last 10 days, according to various share statistics. A total of 14.18M shares are outstanding, with a floating share count of 13.48M. Insiders hold about 4.98% of the company’s shares, while institutions hold 1.44% stake in the company. Shares short for TNFA as of 1752537600 were 2623100 with a Short Ratio of 0.13, compared to 1749772800 on 3599757. Therefore, it implies a Short% of Shares Outstanding of 2623100 and a Short% of Float of 18.540001.
